Xgeva 120 MG/1.7 ML vial 1.7ML
Ended Awarded
- Contract number
- SPE2DB25FCZVC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,051
Award facts
- Contract value 100% obligated
- $12,051.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,051.37 to AmerisourceBergen Drug Corp for XGEVA 120 mg/1.7 ml vials on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. XGEVA (denosumab) is a monoclonal antibody used to treat bone metastases and other conditions involving bone loss, representing a specialized pharmaceutical product within the Defense Logistics Agency's medical supply chain.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems worldwide. The parent IDC serves as a global pharmaceutical support vehicle enabling the company to fulfill recurring medical supply needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FCZVC?
SPE2DB25FCZVC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 22, 2025.
How much is contract SPE2DB25FCZVC worth?
The government has obligated $12,051 on SPE2DB25FCZVC.
Is contract SPE2DB25FCZVC an order under another contract?
Yes. SPE2DB25FCZVC is a delivery order under SPE2DB24D1205, an indefinite delivery contract.
Was contract SPE2DB25FCZVC competed?
The extent of competition for SPE2DB25FCZVC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award